A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT01711359 · COMPLETED

Trial details

NCT number: NCT01711359
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2012-11-01
Primary completion: 2015-02-01
Enrollment: 588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.